Regeneron Pharmaceuticals (REGN) Current Assets (2009 - 2026)
Regeneron Pharmaceuticals' quarterly Current Assets came in at $18.2 billion in Q1 2026, up 3.63% year-on-year from $17.6 billion in Q1 2025, and up 1.04% quarter-over-quarter from $18.0 billion in Q4 2025.
Regeneron Pharmaceuticals has reported Current Assets for 18 years, with the latest figure at $18.2 billion in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 3.63% year-over-year to $18.2 billion; the trailing twelve-month figure through Mar 2026 stood at $18.2 billion (up 3.63% YoY), and the FY2025 full-year result was $18.0 billion, down 3.42% from the prior year.
- Current Assets for Q1 2026 stood at $18.2 billion, up from $18.0 billion in the prior quarter.
- The five-year high for Current Assets was $19.5 billion in Q4 2023, with the low at $14.3 billion in Q1 2022.
- Average Current Assets over 5 years is $17.5 billion, with a median of $18.0 billion recorded in 2025.
- Year-over-year, Current Assets jumped 42.28% in 2022 and dropped 11.65% in 2025.
- Tracing REGN's Current Assets over 5 years: stood at $15.9 billion in 2022, then advanced by 22.63% to $19.5 billion in 2023, then dropped by 4.2% to $18.7 billion in 2024, then fell by 3.42% to $18.0 billion in 2025, then gained by 1.04% to $18.2 billion in 2026.
- The last three Current Assets figures came in at $18.2 billion (Q1 2026), $18.0 billion (Q4 2025), and $18.0 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 1.97 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.21 Bn |
| Dec 31, 2025 | 18.02 Bn |
| Sep 30, 2025 | 17.98 Bn |
| Jun 30, 2025 | 16.86 Bn |
| Mar 31, 2025 | 17.57 Bn |
| Dec 31, 2024 | 18.66 Bn |
| Sep 30, 2024 | 19.33 Bn |
| Jun 30, 2024 | 19.08 Bn |
| Mar 31, 2024 | 18.87 Bn |
| Dec 31, 2023 | 19.48 Bn |
| Sep 30, 2023 | 18.63 Bn |
| Jun 30, 2023 | 16.92 Bn |
| Mar 31, 2023 | 16.91 Bn |
| Dec 31, 2022 | 15.88 Bn |
| Sep 30, 2022 | 15.43 Bn |
| Jun 30, 2022 | 15.53 Bn |
| Mar 31, 2022 | 14.31 Bn |
| Dec 31, 2021 | 14.01 Bn |
| Sep 30, 2021 | 13.78 Bn |
| Jun 30, 2021 | 13.34 Bn |
| Mar 31, 2021 | 10.06 Bn |
| Dec 31, 2020 | 9.78 Bn |
| Sep 30, 2020 | 9.10 Bn |
| Jun 30, 2020 | 7.86 Bn |
| Mar 31, 2020 | 8.64 Bn |
| Dec 31, 2019 | 7.69 Bn |
| Sep 30, 2019 | 7.11 Bn |
| Jun 30, 2019 | 6.65 Bn |
| Mar 31, 2019 | 6.93 Bn |
| Dec 31, 2018 | 6.45 Bn |
| Sep 30, 2018 | 5.72 Bn |
| Jun 30, 2018 | 4.81 Bn |
| Mar 31, 2018 | 4.54 Bn |
| Dec 31, 2017 | 4.34 Bn |
| Sep 30, 2017 | 4.14 Bn |
| Jun 30, 2017 | 3.86 Bn |
| Mar 31, 2017 | 3.67 Bn |
| Dec 31, 2016 | 3.18 Bn |
| Sep 30, 2016 | 3.50 Bn |
| Jun 30, 2016 | 3.21 Bn |
| Mar 31, 2016 | 3.13 Bn |
| Dec 31, 2015 | 2.92 Bn |
| Sep 30, 2015 | 2.68 Bn |
| Jun 30, 2015 | 2.28 Bn |
| Mar 31, 2015 | 2.31 Bn |
| Dec 31, 2014 | 2.08 Bn |
| Sep 30, 2014 | 2.20 Bn |
| Jun 30, 2014 | 1.92 Bn |
| Mar 31, 2014 | 1.87 Bn |
| Dec 31, 2013 | 1.80 Bn |
| Sep 30, 2013 | 1.63 Bn |
| Jun 30, 2013 | 1.56 Bn |
| Mar 31, 2013 | 1.31 Bn |
| Dec 31, 2012 | 1.21 Bn |
| Sep 30, 2012 | 948.60 Mn |
| Jun 30, 2012 | 769.19 Mn |
| Mar 31, 2012 | 696.92 Mn |
| Dec 31, 2011 | 665.78 Mn |
| Sep 30, 2011 | 339.87 Mn |
| Jun 30, 2011 | 413.27 Mn |
| Mar 31, 2011 | 325.50 Mn |
| Dec 31, 2010 | 357.62 Mn |
| Sep 30, 2010 | 575.72 Mn |
| Jun 30, 2010 | 417.75 Mn |
| Dec 31, 2009 | 425.51 Mn |